Hypoxia-activated prodrugs and redox-responsive nanocarriers

about

Hypoxia-activated prodrugs and redox-responsive nanocarriers

Item

http://www.wikidata.org/entity/Q58694676

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 18 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@en

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@nl

type

Item

label

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@en

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@nl

prefLabel

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@en

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@nl

P1476

Hypoxia-activated prodrugs and redox-responsive nanocarriers

@en

P2093

Jimin Liang

http://www.w3.org/2001/XMLSchema#string

Jingwen Ma

http://www.w3.org/2001/XMLSchema#string

Qi Zeng

http://www.w3.org/2001/XMLSchema#string

Xinyi Xu

http://www.w3.org/2001/XMLSchema#string

Xueli Chen

http://www.w3.org/2001/XMLSchema#string

Yonghua Zhan

http://www.w3.org/2001/XMLSchema#string

Yun Zeng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones

Redox activation of metal-based prodrugs as a strategy for drug delivery

Targeting HIF-1 for cancer therapy

Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104

Targeting hypoxia in cancer therapy

Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.

Synthesis and cytotoxicity of pyranonaphthoquinone natural product analogues under bioreductive conditions.

Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide

Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition

The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release.

P304

6551-6574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/IJN.S173431

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qi Zeng

P5008

ScienceSource

P577

2018-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30425475

http://www.w3.org/2001/XMLSchema#string

P921

pharmaceutical preparation

Biofiseg

P932

6202002

http://www.w3.org/2001/XMLSchema#string